BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30272600)

  • 1. Mastocytosis.
    Birn CS
    Gastroenterol Nurs; 2018; 41(5):380-387. PubMed ID: 30272600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal manifestations of systemic mastocytosis.
    Lee JK; Whittaker SJ; Enns RA; Zetler P
    World J Gastroenterol; 2008 Dec; 14(45):7005-8. PubMed ID: 19058339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal involvement and manifestations in systemic mastocytosis.
    Sokol H; Georgin-Lavialle S; Grandpeix-Guyodo C; Canioni D; Barete S; Dubreuil P; Lortholary O; Beaugerie L; Hermine O
    Inflamm Bowel Dis; 2010 Jul; 16(7):1247-53. PubMed ID: 20162539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
    Hahn HP; Hornick JL
    Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal Manifestations of Hypereosinophilic Syndromes and Mast Cell Disorders: a Comprehensive Review.
    Nanagas VC; Kovalszki A
    Clin Rev Allergy Immunol; 2019 Oct; 57(2):194-212. PubMed ID: 30003499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mastocytosis in childhood].
    Renke J; Lange M
    Przegl Lek; 2006; 63(7):551-3. PubMed ID: 17203807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical challenge for gastroenterologists-Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review.
    Elvevi A; Elli EM; Lucà M; Scaravaglio M; Pagni F; Ceola S; Ratti L; Invernizzi P; Massironi S
    World J Gastroenterol; 2022 Aug; 28(29):3767-3779. PubMed ID: 36157547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal manifestations in mastocytosis: a study of 83 patients.
    Sokol H; Georgin-Lavialle S; Canioni D; Barete S; Damaj G; Soucie E; Bruneau J; Chandesris MO; Suarez F; Launay JM; Aouba A; Grandpeix-Guyodo C; Lanternier F; Grosbois B; de Gennes C; Cathébras P; Fain O; Hoyeau-Idrissi N; Dubreuil P; Lortholary O; Beaugerie L; Ranque B; Hermine O
    J Allergy Clin Immunol; 2013 Oct; 132(4):866-73.e1-3. PubMed ID: 23890756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are Enterocolic Mucosal Mast Cell Aggregates Clinically Relevant in Patients Without Suspected or Established Systemic Mastocytosis?
    Johncilla M; Jessurun J; Brown I; Hornick JL; Bellizzi AM; Shia J; Yantiss RK
    Am J Surg Pathol; 2018 Oct; 42(10):1390-1395. PubMed ID: 30001235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vulvar oedema revealing systemic mastocytosis].
    Deveza E; Locatelli F; Girardin M; Valmary-Degano S; Daguindau E; Aubin F; Humbert P; Pelletier F
    Ann Dermatol Venereol; 2015 Nov; 142(11):685-9. PubMed ID: 26003033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of octreotide for relief of gastro-intestinal (GI) symptoms in systemic mastocytosis.
    Sadashiv S; Bower K; Sahovic E; Bunker M; Christou A
    Hematol Oncol Stem Cell Ther; 2013 Jun; 6(2):72-5. PubMed ID: 23712217
    [No Abstract]   [Full Text] [Related]  

  • 13. Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study.
    Gruson B; Lortholary O; Canioni D; Chandesris O; Lanternier F; Bruneau J; Grosbois B; Livideanu C; Larroche C; Durieu I; Barete S; Sevestre H; Diouf M; Chaby G; Marolleau JP; Dubreuil P; Hermine O; Damaj G
    Br J Haematol; 2013 May; 161(3):434-42. PubMed ID: 23432617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical care management of systemic mastocytosis: when every wasp is a killer bee.
    van der Weide HY; van Westerloo DJ; van den Bergh WM
    Crit Care; 2015 Jun; 19(1):238. PubMed ID: 26036415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
    Azaña JM; Torrelo A; Matito A
    Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indolent systemic mastocytosis: a case and review of the current available treatment options.
    Lee Y; Wood P; Soyer HP
    Dermatol Online J; 2013 Jun; 19(6):18562. PubMed ID: 24011312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mastocytosis.
    Abid A; Malone MA; Curci K
    Prim Care; 2016 Sep; 43(3):505-18. PubMed ID: 27545739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic mastocytosis.
    Akin C; Metcalfe DD
    Annu Rev Med; 2004; 55():419-32. PubMed ID: 14746529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current approaches to the diagnosis and treatment of systemic mastocytosis.
    Bains SN; Hsieh FH
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):1-10; quiz 10-2, 41. PubMed ID: 20143640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.